shadow_tr

Myeloma Studies
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -


E3A06 (CTSU)
Randomized Phase III Trial of Lenalidomide versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
More Information


MERCK 3475-183
A Phase III Study of Pomalidomide and Low-Dose Dexamethasone With or Without Pembrolizumab (MK3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM). (KEYNOTE 183)
More Information


MERCK 3475-185

A Plase III Study of Lenalidomide and Low-Dose Dexamethasone With or Without Pembrolizumab (MK3475) in Newly Diagnosed and Treatment Naive Multiple Myeloma (KEYNOTE 185)
More Information


 

1430 Tulane Ave, New Orleans, LA 70112 medsch@tulane.edu